BSE Live
Jan 15, 15:59Prev. Close
3.97
Open Price
4.06
Bid Price (Qty.)
4.11 (2390)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jan 11, 15:18Prev. Close
4.15
Open Price
4.40
Bid Price (Qty.)
4.20 (500)
Offer Price (Qty.)
4.25 (2249)
| Key Financial Ratios of Jupiter Bioscience (in Rs. Cr.) | Mar 11 | Mar 10 | Mar 09 | Mar 08 | Mar 07 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 6.02 | 19.11 | 17.47 | 14.91 | 19.08 | |
| Diluted EPS (Rs.) | 6.02 | 19.11 | 17.47 | 14.91 | 19.08 | |
| Cash EPS (Rs.) | 13.06 | 43.17 | 35.98 | 26.47 | 36.10 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 120.73 | 200.85 | 184.08 | 161.27 | 146.33 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 120.73 | 200.85 | 184.08 | 161.27 | 146.33 | |
| Dividend / Share(Rs.) | 1.00 | 2.00 | 2.00 | 2.00 | 2.25 | |
| Revenue from Operations/Share (Rs.) | 40.54 | 114.01 | 88.59 | 71.58 | 105.45 | |
| PBDIT/Share (Rs.) | 17.61 | 59.28 | 46.94 | 32.91 | 46.09 | |
| PBIT/Share (Rs.) | 10.48 | 37.46 | 30.68 | 23.35 | 32.74 | |
| PBT/Share (Rs.) | 6.40 | 23.11 | 19.89 | 17.30 | 25.83 | |
| Net Profit/Share (Rs.) | 5.35 | 19.11 | 17.47 | 14.91 | 19.08 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 43.42 | 51.99 | 52.97 | 45.96 | 43.70 | |
| PBIT Margin (%) | 25.85 | 32.85 | 34.62 | 32.61 | 31.04 | |
| PBT Margin (%) | 15.78 | 20.26 | 22.44 | 24.16 | 24.49 | |
| Net Profit Margin (%) | 13.20 | 16.75 | 19.72 | 20.82 | 18.09 | |
| Return on Networth / Equity (%) | 4.43 | 9.51 | 9.49 | 9.24 | 13.03 | |
| Return on Capital Employed (%) | 4.06 | 4.19 | 4.94 | 5.82 | 6.32 | |
| Return on Assets (%) | 2.67 | 3.90 | 4.45 | 5.20 | 5.36 | |
| Total Debt/Equity (X) | 0.53 | 1.22 | 0.93 | 0.65 | 1.14 | |
| Asset Turnover Ratio (%) | 20.28 | 23.30 | 22.61 | 24.97 | 29.66 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 0.48 | 2.51 | 1.87 | 1.78 | 1.43 | |
| Quick Ratio (X) | 0.32 | 1.43 | 1.06 | 1.01 | 0.79 | |
| Inventory Turnover Ratio (X) | 3.76 | 3.10 | 2.88 | 3.03 | 3.08 | |
| Dividend Payout Ratio (NP) (%) | 18.68 | 10.46 | 11.44 | 13.41 | 11.79 | |
| Dividend Payout Ratio (CP) (%) | 7.65 | 4.63 | 5.55 | 7.55 | 6.23 | |
| Earnings Retention Ratio (%) | 81.32 | 89.54 | 88.56 | 86.59 | 88.21 | |
| Cash Earnings Retention Ratio (%) | 92.35 | 95.37 | 94.45 | 92.45 | 93.77 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 517.67 | 525.01 | 336.82 | 449.71 | 305.27 | |
| EV/Net Operating Revenue (X) | 2.05 | 2.85 | 2.36 | 3.46 | 2.94 | |
| EV/EBITDA (X) | 4.71 | 5.49 | 4.45 | 7.54 | 6.72 | |
| MarketCap/Net Operating Revenue (X) | 0.49 | 0.73 | 0.42 | 2.01 | 1.37 | |
| Retention Ratios (%) | 81.31 | 89.53 | 88.55 | 86.58 | 88.20 | |
| Price/BV (X) | 0.16 | 0.42 | 0.20 | 0.89 | 0.99 | |
| Price/Net Operating Revenue | 0.49 | 0.73 | 0.42 | 2.01 | 1.37 | |
| Earnings Yield | 0.27 | 0.23 | 0.47 | 0.10 | 0.13 |